Navigation Links
Visual Healthcare Provides Fourth Quarter Revenue Guidance
Date:6/15/2011

RENO, Nev., June 15, 2011 /PRNewswire/ -- Visual Healthcare Corp. (the "Company") (NASDAQ OTC: VSHC) is pleased to be able to announce today that it expects revenues for the fourth quarter of fiscal 2011 to be between $1,050,000 and $1,150,000. The mid-range of the current guidance is a record high since inception and represents a substantial increase from previous quarters in 2011. Based on these figures the Company can provide further guidance regarding year end revenues for the entire year which is expected to be between $1,460,000 and $1,550,000.

Final year end results will be released on August 30th, 2011. The Company will hold a conference call to discuss 2011 financial results Wednesday, August 31st, 2011, at 11:00 AM EDT. Contact information will be provided on company website.

Company Chairman, Mr. Gerard Dab largely credits changing conditions in the American healthcare market, including new regulations, for the company performance in 2011. New products and services have been ushered in but would not have been as well received if the market had not been more receptive than ever before in the company's 12 year history.

ABOUT VISUAL HEALTHCARE

Visual Healthcare Corp., since 1998, designs, creates and develops innovative information platforms, specifically conceived for the automation of a wide range of scientific disciplines. These include pharmaceutical research, clinical trials, laboratory automation, true quality assurance tools, total quality control applications.  They also include quantitative analytic tools such as proprietary frameworks for electronic health records, electronic prescription, infection and disease control, and smart cancer registries. The company's extensive portfolio of proprietary technologies is the result of a unique collaboration between senior clinicians from the McGill University Faculty of Medicine and affiliated tertiary care centers, medical software architects, and a Fortune 100 healthcare service company, investing some $50 million in the process. The Company licenses its technology to operating companies in exchange for an equity stake or a royalty stream. It owns significant stakes in various companies including VisualMED Clinical Solutions Corp. (NASDAQ OTC: VMCS), a leader in the field of electronic health records.

For more information, please visit: www.visualhealthcarecorp.com.

FORWARD- LOOKING STATEMENTS

Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.

Contact:

Gerard Dab, CEO
Visual Healthcare Corp.
514-582-5220


'/>"/>
SOURCE Visual Healthcare Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. In a New Audio Interview at SmallCapVoice.com, Gerard Dab, Chairman and CEO of Visual Healthcare Corp., Provides Details Regarding Recent News
2. Increased Demand for Visual Healthcare ADE Prevention Platform
3. Boston Scientifics SpyGlass® Direct Visualization System Achieves Global Utilization Milestones
4. Visual Healthcare to Support Chinese Clinical Trials
5. SpineSmith Successful in VisuALIF Alpha Launch
6. Two Laser Balloon Live Cases Shed New Light on Direct Visualization and PV Ablation
7. Chemistry Researchers Create New Tool to Visualize Bloodstains
8. The Truth About Diabetes and Visual Complications Unveiled
9. Reportlinker Adds Endoscopy Devices Market Outlook in Belgium to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others
10. SpineSmith Partners Announces FDA Clearance and Product Launch of VisuALIF Interbody Fusion Device at North American Spine Society Annual Meeting
11. NIST-traceable Temperature Tracking Provides Visual Alert RadarFind Sensor Now Waterproof Certified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... 2017 Research and Markets has announced the ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ... ... will rise from USD 20 Billion in 2015 to around USD ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ...
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical Therapy (PRPT) ... preferred physical therapy provider for Derby City CrossFit, effective immediately. , In addition ... quickly and effectively as possible, ProRehab’s sports physical therapists will work with athletes ...
(Date:4/25/2017)... ... April 25, 2017 , ... A ... student test score performance for the 2015-16 school year across Wisconsin’s public schools, ... Though it highlights important patterns in student test score performance, the report’s limited ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical ... partners to help with process innovation in drug formulation and manufacturing. CoreRx ... with state-of-the-art analytical equipment in support of their development and manufacturing goals. ...
(Date:4/25/2017)... ... ... MD is committed to providing the highest quality of spine care to all his patients. ... all my patients to alleviate possible future issues. I am pleased to have you as ... my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary is ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
Breaking Medicine News(10 mins):